aslan pharmaceuticals

ASLAN And Bukwang Team Up To Develop Immune-Oncology Drugs

The joint venture has resulted in the independent company JAGUAHR Therapeutics, which will focus on developing aryl hydrocarbon receptor antagonists for cancer treatment.

ASLAN Partners BioGenetics To Commercialize Varlitinib

ASLAN Pharmaceuticals will focus on clinical development of varlitinib while BioGenetics will obtain the necessary regulatory approvals for the use of the drug in South Korea.